Bessemer Group Portfolio holdings
AUM
$61.6B
1-Year Return
25.88%
This Quarter Return
+6.38%
1 Year Return
+25.88%
3 Year Return
+112.29%
5 Year Return
+188.53%
10 Year Return
+439.25%
AUM
$25.8B
AUM Growth
+$703M
(+2.8%)
Cap. Flow
-$918M
Cap. Flow
% of AUM
-3.56%
Top 10 Holdings %
Top 10 Hldgs %
17.94%
Holding
1,941
New
141
Increased
415
Reduced
709
Closed
240
Top Buys
| 1 |
Walt Disney
DIS
|
$170M |
| 2 |
Zoetis
ZTS
|
$152M |
| 3 |
Chevron
CVX
|
$124M |
| 4 |
Quest Diagnostics
DGX
|
$87.6M |
| 5 |
L3Harris
LHX
|
$86.3M |
Top Sells
| 1 |
Union Pacific
UNP
|
$164M |
| 2 |
Hanesbrands
HBI
|
$125M |
| 3 |
Edison International
EIX
|
$120M |
| 4 |
Newell Brands
NWL
|
$94M |
| 5 |
Gilead Sciences
GILD
|
$93.1M |
Sector Composition
| 1 | Financials | 14.91% |
| 2 | Technology | 13.53% |
| 3 | Healthcare | 12.53% |
| 4 | Consumer Discretionary | 10.78% |
| 5 | Consumer Staples | 9.55% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
326
Emerson Electric
EMR
$74.7B
| $2.7M | 0.01% |
38,698
+1,770
| +5% | +$123K |
|
327
Curtiss-Wright
CW
$18.2B
| $2.55M | 0.01% |
20,900
-9,278
| -31% | -$1.13M |
|
328
MidCap Financial Investment
MFIC
$1.21B
| $2.51M | 0.01% |
147,611
| – | – |
|
329
Chemed
CHE
$6.76B
| $2.49M | 0.01% |
10,252
-5,015
| -33% | -$1.22M |
|
330
Churchill Downs
CHDN
$7.01B
| $2.47M | 0.01% |
63,798
-30,612
| -32% | -$1.19M |
|
331
Invesco Advantage Municipal Income Trust II
VKI
$381M
| $2.45M | 0.01% |
215,660
-7,549
| -3% | -$85.9K |
|
332
EPAM Systems
EPAM
$9.16B
| $2.44M | 0.01% |
22,700
-8,600
| -27% | -$924K |
|
333
H&R Block
HRB
$6.97B
| $2.44M | 0.01% |
92,920
+21,319
| +30% | +$559K |
|
|
AET
334
DELISTED
Aetna Inc
AET
| $2.41M | 0.01% |
13,363
+2,205
| +20% | +$398K |
|
335
Murphy Oil
MUR
$3.61B
| $2.41M | 0.01% |
77,521
+5,646
| +8% | +$175K |
|
|
AZPN
336
DELISTED
ASPEN TECHNOLOGY INC
AZPN
| $2.38M | 0.01% |
36,000
-14,400
| -29% | -$953K |
|
|
SLCA
337
DELISTED
U.S. SILICA HOLDINGS, INC.
SLCA
| $2.38M | 0.01% |
+73,000
| New | +$2.38M |
|
338
Core Laboratories
CLB
$582M
| $2.37M | 0.01% |
21,677
+2,313
| +12% | +$253K |
|
339
Tetra Tech
TTEK
$9.38B
| $2.37M | 0.01% |
245,550
-82,000
| -25% | -$790K |
|
340
Nuveen AMT-Free Municipal Credit Income Fund
NVG
$2.6B
| $2.36M | 0.01% |
153,000
| – | – |
|
341
Ryman Hospitality Properties
RHP
$6.33B
| $2.36M | 0.01% |
34,168
-11,635
| -25% | -$803K |
|
342
Fair Isaac
FICO
$36.9B
| $2.32M | 0.01% |
15,121
-5,902
| -28% | -$904K |
|
343
Vanguard FTSE Developed Markets ETF
VEA
$173B
| $2.3M | 0.01% |
51,331
+14,531
| +39% | +$652K |
|
344
Selective Insurance
SIGI
$4.85B
| $2.3M | 0.01% |
39,200
-16,900
| -30% | -$992K |
|
345
Allete
ALE
$3.68B
| $2.3M | 0.01% |
30,900
-12,002
| -28% | -$893K |
|
346
National Healthcare
NHC
$1.8B
| $2.28M | 0.01% |
37,443
-4,000
| -10% | -$244K |
|
347
SPDR Gold Trust
GLD
$113B
| $2.27M | 0.01% |
18,361
-2,500
| -12% | -$309K |
|
348
Progress Software
PRGS
$1.86B
| $2.24M | 0.01% |
52,700
-26,300
| -33% | -$1.12M |
|
|
VVC
349
DELISTED
Vectren Corporation
VVC
| $2.22M | 0.01% |
34,136
-12,025
| -26% | -$782K |
|
350
Haemonetics
HAE
$2.61B
| $2.21M | 0.01% |
38,000
-20,700
| -35% | -$1.2M |
|